Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Pabinger

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 6, 2013
Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillationM K Freynhofer, D F Draxler, S C Gruber, et al.
Thrombosis and Haemostasis|May 1, 1997
Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolismP A Kyrle, S Eichinger, I Pabinger, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2016
Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIIIM T Reding, H J Ng, L H Poulsen, et al.
Gastroenterology|July 1, 1997
Wilson's disease in patients presenting with liver disease: a diagnostic challengeP Steindl, P Ferenci, H P Dienes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2016
Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgeryC Négrier, F Abdul Karim, L M Lepatan, et al.
Thrombosis and Haemostasis|April 22, 1985
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDST L Chorba, J M Jason, R B Ramsey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2023
Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineA Falanga, C Ay, M Di Nisio, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2012
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasmaM E Gorczyca, S C Nair, B Jilma, et al.
Annals of Hematology|December 1, 1996
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemiaI M Huhmann, H H Watzke, K Geissler, et al.
Annals of Hematology|October 1, 1996
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemiaM Mitterbauer, M Fritzer-Szekeres, G Mitterbauer, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Journal of Thrombosis and Haemostasis : JTH|April 6, 2013
Endogenous t-PA-antigen is an independent predictor of adverse cardiovascular events and all-cause death in patients with atrial fibrillationM K Freynhofer, D F Draxler, S C Gruber, et al.
Thrombosis and Haemostasis|May 1, 1997
Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolismP A Kyrle, S Eichinger, I Pabinger, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2016
Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIIIM T Reding, H J Ng, L H Poulsen, et al.
Gastroenterology|July 1, 1997
Wilson's disease in patients presenting with liver disease: a diagnostic challengeP Steindl, P Ferenci, H P Dienes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2016
Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgeryC Négrier, F Abdul Karim, L M Lepatan, et al.
Thrombosis and Haemostasis|April 22, 1985
HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDST L Chorba, J M Jason, R B Ramsey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2023
Venous thromboembolism in cancer patients: ESMO Clinical Practice GuidelineA Falanga, C Ay, M Di Nisio, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2012
Inhibition of tissue factor pathway inhibitor by the aptamer BAX499 improves clotting of hemophilic blood and plasmaM E Gorczyca, S C Nair, B Jilma, et al.
Annals of Hematology|December 1, 1996
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemiaI M Huhmann, H H Watzke, K Geissler, et al.
Annals of Hematology|October 1, 1996
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemiaM Mitterbauer, M Fritzer-Szekeres, G Mitterbauer, et al.
Pageof 22